S100B protein and neuron-specific enolase as predictors of cognitive dysfunction after coronary artery bypass graft surgery
BACKGROUNDPostoperative cognitive dysfunction (POCD) may be related to the systemic inflammatory response and an increase in serum markers of brain injury such as S100B protein and neuron-specific enolase (NSE). OBJECTIVEThe study aims to evaluate the association between POCD and serum levels of S10...
Saved in:
Published in: | European journal of anaesthesiology |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
European Society of Anaesthesiology
01-09-2016
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | BACKGROUNDPostoperative cognitive dysfunction (POCD) may be related to the systemic inflammatory response and an increase in serum markers of brain injury such as S100B protein and neuron-specific enolase (NSE).
OBJECTIVEThe study aims to evaluate the association between POCD and serum levels of S100B and NSE after coronary artery bypass grafting surgery (CABG).
DESIGNProspective observational study.
SETTINGSingle university teaching hospital.
PATIENTSWe investigated 88 patients undergoing CABG.
MAIN OUTCOMES MEASURESCognitive function was measured preoperatively, and at the 21st and 180th postoperative days (i.e. 6 months after surgery). S100B protein and NSE serum levels were evaluated preoperatively, after induction of anaesthesia, at the end of surgery and at 6 and 24 h after surgery.
RESULTSThe incidence of POCD was 26.1% at 21 days after surgery and 22.7% at 6 months after surgery. Increased serum levels of S100B protein and NSE were observed postoperatively and may indicate brain damage.
CONCLUSIONAlthough serum levels of S100B protein and NSE are both significantly increased postoperatively, our findings indicate that serum levels of S100B protein may be more accurate than NSE in the detection of POCD after CABG.
TRIAL REGISTRATIONNCT01550159. |
---|---|
ISSN: | 0265-0215 1365-2346 |
DOI: | 10.1097/EJA.0000000000000450 |